Jamey P Weichert Selected Research

18-(4-iodophenyl)octadecylphosphocholine (NM 404)

4/2006

Synthesis and structure-activity relationship effects on the tumor avidity of radioiodinated phospholipid ether analogues.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jamey P Weichert Research Topics

Disease

27	Neoplasms (Cancer) 01/2021 - 06/2004
4	Brain Neoplasms (Brain Tumor) 01/2021 - 02/2015
2	Melanoma (Melanoma, Malignant) 01/2021 - 01/2021
2	Neuroblastoma 10/2019 - 01/2015
2	Glioblastoma (Glioblastoma Multiforme) 10/2016 - 02/2015
2	Colorectal Neoplasms (Colorectal Cancer) 01/2014 - 06/2012
1	Bites and Stings (Sting) 01/2021
1	Osteosarcoma (Osteogenic Sarcoma) 01/2021
1	Triple Negative Breast Neoplasms 01/2020
1	Rhabdomyosarcoma 10/2019
1	Ewing Sarcoma (Sarcoma, Ewing) 10/2019
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2019
1	Head and Neck Neoplasms (Head and Neck Cancer) 09/2015
1	Acquired Immunodeficiency Syndrome (AIDS) 02/2015
1	Glioma (Gliomas) 02/2015
1	Intestinal Neoplasms (Intestinal Cancer) 01/2014
1	Colonic Neoplasms (Colon Cancer) 01/2014
1	Adenocarcinoma 01/2014
1	Hyperplasia 06/2012
1	Lung Neoplasms (Lung Cancer) 04/2006

Drug/Important Bio-Agent (IBA)

10	CLR1404IBA 01/2020 - 01/2014
8	Radioisotopes (Radionuclides)IBA 01/2021 - 01/2014
6	Phospholipids (Phosphatides)FDA LinkGeneric 10/2019 - 04/2006
5	Ether (Diethyl Ether)IBA 10/2019 - 04/2006
3	Phosphorylcholine (Phosphocholine)IBA 01/2018 - 01/2015
3	Pharmaceutical PreparationsIBA 01/2018 - 08/2010
2	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2021
2	Phospholipid EthersIBA 01/2016 - 06/2014
2	CLR1502IBA 02/2015 - 01/2014
2	AcidsIBA 02/2015 - 08/2010
1	Interleukin-13IBA 01/2021
1	ChemokinesIBA 01/2021
1	Yttrium-86IBA 01/2021
1	InterferonsIBA 01/2021
1	Interleukin-2 (IL2)IBA 01/2021
1	CytokinesIBA 01/2021
1	Interleukin-10 (Interleukin 10)IBA 01/2021
1	lorukafusp alfaIBA 01/2021
1	Excipients (Suspending Agents)IBA 01/2020
1	LipidsIBA 01/2020
1	3-Iodobenzylguanidine (Iobenguane)IBA 10/2019
1	RadiopharmaceuticalsIBA 10/2019
1	Radiation-Sensitizing AgentsIBA 11/2018
1	DNA (Deoxyribonucleic Acid)IBA 11/2018
1	GadoliniumIBA 07/2017
1	Fluorescent Dyes (Fluorescent Probes)IBA 02/2015
1	IodineIBA 01/2015
1	Antineoplastic Agents (Antineoplastics)IBA 01/2015
1	Calcibiotic Root Canal SealerIBA 01/2014
1	Ribosomal Protein S6IBA 01/2013
1	Sirolimus (Rapamycin)FDA Link 01/2013
1	Proteins (Proteins, Gene)FDA Link 06/2012
1	Phosphotransferases (Kinase)IBA 06/2012
1	Phosphatidylinositols (Phosphatidylinositol)IBA 06/2012
1	Piroxicam (Feldene)FDA LinkGeneric 12/2009
1	Fluorouracil (Carac)FDA LinkGeneric 12/2009
1	NM 324IBA 04/2006
1	Iodine-124IBA 04/2006
1	IsotopesIBA 04/2006
1	18-(4-iodophenyl)octadecylphosphocholine (NM 404)IBA 04/2006
1	Carboxypeptidases A (Carboxypeptidase A)IBA 05/2005
1	monomethoxypolyethylene glycol (MPEG)IBA 05/2005
1	Ethylene Glycol (Monoethylene Glycol)IBA 05/2005
1	Contrast MediaIBA 06/2004

Therapy/Procedure

9	Therapeutics 01/2021 - 03/2005
7	Radiotherapy 01/2021 - 01/2017
3	Precision Medicine 01/2021 - 01/2019
2	Intravenous Injections 01/2018 - 01/2015
1	Immunotherapy 01/2021
1	Injections 01/2021
1	Aftercare (After-Treatment) 01/2013